{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260617680929/en/Verastem-Oncology-Announces-Positive-Updated-Results-from-RAMP-205-Evaluating-Avutometinib-Plus-Defactinib-in-Combination-with-Standard-of-Care-Chemotherapy-in-First-Line-Metastatic-Pancreatic-Cancer", "message": "News view counter 804267 successfully enlarged"}